Chen Yarong, Xu Lulu, Cheng Zhiyuan, Zhang Desheng, Yang Jingli, Yin Chun, Li Siyu, Li Jing, Hu Yujia, Wang Yufeng, Liu Yanyan, Wang Zhongge, Zhang Lizhen, Chen Ruirui, Dou Qian, Bai Yana
Institution of Epidemiology and Statistics, School of Public Health, Lanzhou University, 199 Donggang West Road, Lanzhou, Gansu 730000, China.
School of Public Health and Emergency Management, Southern University of Science and Technology, 1088 xueyuan Street, Shenzhen, Guangdong 518055, China.
Eur J Prev Cardiol. 2023 Oct 10;30(14):1482-1491. doi: 10.1093/eurjpc/zwad196.
To quantify the trajectories from normoglycaemia to pre-diabetes, subsequently to type 2 diabetes mellitus (T2DM), cardiovascular diseases (CVD), and cardiovascular death, and the effects of risk factors on the rates of transition.
We used data from the Jinchang Cohort of 42 585 adults aged 20-88 free of coronary heart disease (CHD) and stroke at baseline. A multistate model was applied for analysing the progression of CVD and its relation to various risk factors. During a median follow-up of 7 years, 7498 participants developed pre-diabetes, 2307 developed T2DM, 2499 developed CVD, and 324 died from CVD. Among 15 postulated transitions, transition from comorbid CHD and stroke to cardiovascular death had the highest rate (157.21/1000 person-years), followed by transition from stroke alone to cardiovascular death (69.31/1000 person-years) and transition from pre-diabetes to normoglycaemia (46.51/1000 person-years). Pre-diabetes had a sojourn time of 6.77 years, and controlling weight, blood lipids, blood pressure, and uric acid within normal limits may promote reversion to normoglycaemia. Among transitions to CHD alone and stroke alone, transition from T2DM had the highest rate (12.21/1000 and 12.16/1000 person-years), followed by transition from pre-diabetes (6.81/1000 and 4.93/1000 person-years) and normoglycaemia (3.28/1000 and 2.39/1000 person-years). Age and hypertension were associated with an accelerated rate for most transitions. Overweight/obesity, smoking, dyslipidaemia, and hyperuricaemia played crucial but different roles in transitions.
Pre-diabetes was the optimal intervention stage in the disease trajectory. The derived transition rates, sojourn time, and influence factors could provide scientific support for the primary prevention of both T2DM and CVD.
量化从血糖正常到糖尿病前期,随后发展为2型糖尿病(T2DM)、心血管疾病(CVD)以及心血管死亡的轨迹,以及危险因素对转变发生率的影响。
我们使用了金昌队列中42585名年龄在20 - 88岁之间、基线时无冠心病(CHD)和中风的成年人的数据。应用多状态模型分析CVD的进展及其与各种危险因素的关系。在中位随访7年期间,7498名参与者发展为糖尿病前期,2307名发展为T2DM,2499名发展为CVD,324名死于CVD。在15种假定的转变中,从合并CHD和中风到心血管死亡的转变发生率最高(157.21/1000人年),其次是从中风单独到心血管死亡(69.31/1000人年)以及从糖尿病前期到血糖正常(46.51/1000人年)。糖尿病前期的停留时间为6.77年,将体重、血脂、血压和尿酸控制在正常范围内可能促进恢复到血糖正常状态。在单独转变为CHD和单独转变为中风的情况中,从T2DM转变的发生率最高(12.21/1000和12.16/1000人年),其次是从糖尿病前期转变(6.81/1000和4.93/1000人年)以及血糖正常转变(3.28/1000和2.39/1000人年)。年龄和高血压与大多数转变的加速发生率相关。超重/肥胖、吸烟、血脂异常和高尿酸血症在转变中起关键但不同的作用。
糖尿病前期是疾病轨迹中的最佳干预阶段。得出的转变发生率、停留时间和影响因素可为T2DM和CVD的一级预防提供科学支持。